Peer Review History

Original SubmissionJune 23, 2022
Decision Letter - Catalina Castaño, Editor

PONE-D-22-17743Physical activity mitigates the link between Adverse Childhood Experiences and Depression among U.S. adultsPLOS ONE

Dear Dr. Royer,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Please submit your revised manuscript by Oct 08 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Catalina Castaño, M.D, MSc

Guest Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please ensure that you include a title page within your main document. You should list all authors and all affiliations as per our author instructions and clearly indicate the corresponding author.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments: 

Your article is significant because it addresses the importance of non-medical interventions in preventing mental health pathology. Your paper is well written, but I agree with Reviewer Nº1 that the abstract should be rewritten under his suggestions, focusing on the results. 

Overall I agree with the reviewer's suggestion; I think that background, methods and results are sound and wouldn´t make significant changes. Still, I have the same question as reviewer Nº2: Was pharmacologic treatment (previous or ongoing) a survey variable? Did they undergo or were under therapy? I think you should address that issue under discussion or limitations.

 [Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

Thank you for your excellent effort to publish your research work, it is an important study. Here are some comments and suggestions for you.

Starting from keywords, you are listed many words and decrease to four to six words, and use only relevant words.

In the abstract, you did not write the main objective and significance of the study which is very important to write in the background under the abstract. In addition, you took the content of the abstract directly from the body part of your research. But, it should be paraphrased or other similar words.

Introduction is good. But, in the methodology, the sampling techniques and procedures did not clearly state. so, make it clear. The result, discussion, and conclusion are good. But, state them in a short and precise way.

Reviewer #2: The article is relevant and highlights observable facts in all disciplines of medicine that have been minimized or "denied" by clinics that relegate such observations. It suggests that due to possible difficulties of culture and researchers, which historically tends to normalize damage to the health of minors in neglectful or violent and vulnerable environments. In this order of ideas, the contribution of this article gives us excellent support on how epidemiology is a good way of working for health and prevention. It was a pleasure to read and observe this collaborative work of the epidemiological surveillance centers of so many states that corroborates what is in our daily clinical practice with a methodological and statistical clarity of great help for future developments and treatments; with an n that gives an excellent value to the research for its diversity of populations in a single study. Adverse childhood experiences, depression, and exercise show new directions in holistic medicine and collaborative research. Each one is a subject as a variable with higher risk factors for many diseases and higher mortality. If we study it together and understand how each works to increase or decrease healthy living, we can help people in a better way. The limitations are well established and explained, with the suggestion of prospective longitudinal studies in the future. Literature is appropriate and fair. I suggest adding new chapter studies with a representative in vivo sample (as a gold standard) will reinforce the results. It does recommend adding an evaluation of the subjects by the clinician to know the reliable or specific depression diagnostic instruments.

Question: How many people are taking medicine during the survey? Or the exercise? It is a posible confusional variable? Are the authors looking for it?

Evidence recommend being careful with this vital variable if working around depressive people and looking to probe any therapy. It is an ethical and methodologic mandatory issue. Please clarify.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Beshir Mammiyo

Reviewer #2: Yes: ADELINA ALCORTA-GARZA

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Editor Comments:

1. Was pharmacologic treatment (previous or ongoing) a survey variable? Did they undergo or were under therapy? I think you should address that issue under discussion or limitations.

Response 1:

Thank you for emphasizing this consideration. The only data for pharmacologic treatment included within the BRFSS dataset was for individuals with a history of cancer or hepatitis B. Please see lines 233-235 of the Discussion section for mention of the lack of a pharmacologic treatment variable as a study limitation.

Reviewer 1 Comments:

1. Starting from keywords, you are listed many words and decrease to four to six words, and use only relevant words.

Response 1:

Thank you for this feedback. I have now decreased the number of keywords to five key words.

2. In the abstract, you did not write the main objective and significance of the study which is very important to write in the background under the abstract.

Response 2:

Thank you for this suggestion. Please see the modifications made to the Abstract, which now includes mention of the study objective and significance.

3. In addition, you took the content of the abstract directly from the body part of your research. But, it should be paraphrased or other similar words.

Response 3:

Edits have now been made to the Abstract in an effort to make the abstract unique from similar content in the main manuscript text.

4. Introduction is good. But, in the methodology, the sampling techniques and procedures did not clearly state. so, make it clear. The result, discussion, and conclusion are good. But, state them in a short and precise way.

Response 4:

Please refer to lines 73-87 concerning the sampling techniques and procedures. Since the BRFSS is an archival dataset, sampling approaches were restricted to including/excluding participant data from the full BRFSS dataset according to whether the state health agency collected data for ACEs, physical activity, and/or depression. Lines 115-117 detail the listwise deletion approach used to remove missing data, which determined the final sample size for our study.

Reviewer 2 Comments:

1. I suggest adding new chapter studies with a representative in vivo sample (as a gold standard) will reinforce the results.

Response 1:

Thank you for this suggestion. Lines 208-216 highlight the only known studies (some in vivo, some not) that have previously examined the links between ACEs and depression, ACEs and physical activity, and physical activity and depression. Lines 208-210 specifically discuss the only known study assessing the role of physical activity within the link between ACEs and depression.

2. It does recommend adding an evaluation of the subjects by the clinician to know the reliable or specific depression diagnostic instruments.

Response 2:

This is certainly an important consideration. Unfortunately, the BRFSS resource page on CDC.gov does not contain information for the specific depression diagnostic instruments used to inform the depression-related items used for the 2020 BRFSS. Please see lines 226-233 in the discussion detailing the limitations of the one-item instrument used to measure both depression and physical activity.

3. Question: How many people are taking medicine during the survey? Or the exercise? It is a posible confusional variable? Are the authors looking for it?

Response 3:

Thank you for bringing attention to this important detail. The only data for participants taking medicine during the survey that is included within the BRFSS dataset is for individuals with a history of cancer or hepatitis B. Please see lines 233-235 of the Discussion section for mention of the lack of a pharmacologic treatment variable as a study limitation.

Attachments
Attachment
Submitted filename: Response to Reviewers - PONE-D-22-17743.docx
Decision Letter - Catalina Castaño, Editor

Physical activity mitigates the link between adverse childhood experiences and depression among U.S. adults

PONE-D-22-17743R1

Dear Dr. Royer,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Catalina Castaño, M.D, MSc

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: It was already commented and all comments were addressed. It is presented with a good fashion and the tittle is sound able

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mammiyo Beshir

**********

Formally Accepted
Acceptance Letter - Catalina Castaño, Editor

PONE-D-22-17743R1

Physical activity mitigates the link between adverse childhood experiences and depression among U.S. adults.

Dear Dr. Royer:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Catalina Castaño

Guest Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .